Methylglyoxal products in pre-symptomatic type 1 diabetes

INTRODUCTION: Progression to type 1 diabetes has emerged as a complex process with metabolic alterations proposed to be a significant driver of disease. Monitoring products of altered metabolism is a promising tool for determining the risk of type 1 diabetes progression and to supplement existing pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuck, Sarah C., Achenbach, Peter, Roep, Bart O., Termini, John S., Hernandez-Castillo, Carlos, Winkler, Christiane, Weiss, Andreas, Ziegler, Anette-Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892703/
https://www.ncbi.nlm.nih.gov/pubmed/36742390
http://dx.doi.org/10.3389/fendo.2023.1108910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892703/
https://www.ncbi.nlm.nih.gov/pubmed/36742390
http://dx.doi.org/10.3389/fendo.2023.1108910

Ejemplares similares